For instance, OXPHOShigh activity has been detected in ibrutinib-resistant mantle cell lymphoma patients [52, 53] and recognizes a subtype of DLBCL insensitive to BCR inhibition [54]. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.